Skip to content

In hindi-Sickling me Drakshavaleha ke prabhaw ka Adhyayan. In english -Study the effect of Drakshavaleha in Sickling.

clinical study to evaluate the efficacy of drakshavleh in management of sickle cell anemia in children

Status
Active, not recruiting
Phases
Phase 1Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/06/025727
Enrollment
60
Registered
2020-06-09
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D570- Hb-SS disease with crisis

Interventions

Intervention1: drakshavaleh: Group A will recieve Drakshavaleh per oral twice daily along with hydroxyurea for 6 month Control Intervention1: comparater agent-tab hydroxyurea(per oral): Group B will r

Sponsors

Dr Damini Sona
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1.patients with clinical manifestation of disease 2.patients with age group05-16years 3.patients who were previously diagnosed and have reliable reports

Exclusion criteria

Exclusion criteria: 1.patients having Hb less than 5 gm %/dl 2.patients with acute chest syndrome 3..patients with variuos complication such as stroke,renal failure,spleen infraction, transfusional iron overload etc

Design outcomes

Primary

MeasureTime frame
comparing episodes of VOC (vaso occulsive crisis) & recurrent blood transfusion before and after treatmentTimepoint: comparing episodes of VOC (vaso occulsive crisis) & recurrent blood transfusion before and after treatment

Secondary

MeasureTime frame
change in subjective and objective parameters after treatmentTimepoint: at the end of six months

Countries

India

Contacts

Public ContactDr Prashant kumar gupta

shri narayan prasad awasthi government ayurved college raipur chhattisgarh

prashantgupta27@gmail.com9990988860

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026